UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors

Journal of cellular biochemistry, 2004-06, Vol.92 (3), p.491-501

2004

Volltextzugriff (PDF)

Predicting Survival in Patients with Metastatic Kidney Cancer by Gene-Expression Profiling in the Primary Tumor

Proceedings of the National Academy of Sciences - PNAS, 2003-06, Vol.100 (12), p.6958-6963

2003

Volltextzugriff (PDF)

GoMiner: a resource for biological interpretation of genomic and proteomic data

Genome biology, 2003-01, Vol.4 (4), p.R28-R28, Article R28

2003

Volltextzugriff (PDF)

Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics

BMC bioinformatics, 2004-06, Vol.5 (1), p.80-80, Article 80

2004

Volltextzugriff (PDF)

The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma

Cancer cell, 2002-04, Vol.1 (3), p.247-255

2002

Volltextzugriff (PDF)

Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma

Cancer, 2013-04, Vol.119 (8), p.1547-1554

2013

Volltextzugriff (PDF)

Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma

Cancer, 2012-12, Vol.118 (23), p.5777-5782

2012

Volltextzugriff (PDF)

Abstract 2819: Efficacy and safety of the Ad-GM·CAIX dendritic cell-based vaccine in treating in vivo metastatic renal cell carcinoma compared to sunitinib monotherapy and simultaneous vaccine-sunitinib combination therapy

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2819-2819

2014

Volltextzugriff (PDF)

1071 POOR PROGNOSIS AND ADVANCED CLINICOPATHOLOGICAL FEATURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC) ARE ASSOCIATED WITH CYTOPLASMIC SUBCELLULAR LOCALIZATION OF HIF-2α

The Journal of urology, 2013-04, Vol.189 (4), p.e439-e440

2013

Volltextzugriff (PDF)

Investigating the association of cytoplasmic and nuclear HIF-2 expression with cancer specific survival (CSS) in clear cell renal cell carcinoma

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.387-387

2013

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models

Journal of immunotherapy (1997), 2013-02, Vol.36 (2), p.102

2013

Volltextzugriff (PDF)

Cancers as wounds that do not heal : Differences and similarities between renal regeneration/repair and renal cell carcinoma

Cancer research (Chicago, Ill.), 2006-07, Vol.66 (14), p.7216-7224

2006

Volltextzugriff (PDF)

437 GAIN OF CHROMOSOME 8Q IS ASSOCIATED WITH METASTASES AND POOR SURVIVAL OF PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA

The Journal of urology, 2012-04, Vol.187 (4), p.e179-e179

2012

Volltextzugriff (PDF)

MP35-06 EFFECTS OF DENDRITIC CELL-BASED AD-GM∙CAIX VACCINE AS MONOTHERAPY OR IN COMBINATION WITH SUNITINIB IN AN IMMUNOCOMPETENT MOUSE MODEL OF METASTATIC RENAL CELL CARCINOMA

The Journal of urology, 2014-04, Vol.191 (4), p.e372-e372

2014

Volltextzugriff (PDF)

Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location

Human mutation, 2004-01, Vol.23 (1), p.40-46

2004

Volltextzugriff (PDF)

Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system

Molecular biology of the cell, 2004-07, Vol.15 (7), p.3042-3052

2004

Volltextzugriff (PDF)

Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience

The cancer journal (Sudbury, Mass.), 2013-05, Vol.19 (3), p.189

2013

Volltextzugriff (PDF)

Safety and efficacy of dendritic cell immunotherapy with ad-GMCAIX in an immunocompetent preclinical tumor model of renal cell carcinoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13045-e13045

2012

Volltextzugriff (PDF)

Abstract 1563: In vivo safety and efficacy of a novel dendritic cell based Ad-GMCAIX vaccine with activity against renal cell carcinoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1563-1563

2012

Volltextzugriff (PDF)

304 DC-AD-GMCAIX BASED VACCINE THERAPY IS SAFE AND EFFECTIVE IN IMMUNOCOMPETENT MURINE KIDNEY CANCER TUMOR MODELS

The Journal of urology, 2012-04, Vol.187 (4), p.e123-e124

2012

Volltextzugriff (PDF)

Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patients

American journal of clinical and experimental immunology, 2014-01, Vol.3 (2), p.84-90

2014

Volltextzugriff (PDF)

Expression of novel alternatively spliced isoforms of the oct-1 transcription factor

Biochimica et biophysica acta, 1999-02, Vol.1444 (2), p.295-298

1999

Volltextzugriff (PDF)

Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor

Biochimica et biophysica acta. Gene structure and expression, 1995-04, Vol.1261 (2), p.201-209

1995

Volltextzugriff (PDF)

Factors to consider when interrogating 3D culture models with plate readers or automated microscopes

In vitro cellular & developmental biology. Animal, 2021-02, Vol.57 (2), p.238-256

2021

Volltextzugriff (PDF)

Functional Outcome After Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation With Intraoperative Cochlear Nerve Monitoring

Otolaryngology-head and neck surgery, 2023-06, Vol.168 (6), p.1502-1510

2023

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(38)
Bücher
(3)

Sprache

Englisch
(40)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors

Predicting Survival in Patients with Metastatic Kidney Cancer by Gene-Expression Profiling in the Primary Tumor

GoMiner: a resource for biological interpretation of genomic and proteomic data

Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics

The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma

Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma

Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma

Abstract 2819: Efficacy and safety of the Ad-GM·CAIX dendritic cell-based vaccine in treating in vivo metastatic renal cell carcinoma compared to sunitinib monotherapy and simultaneous vaccine-sunitinib combination therapy

1071 POOR PROGNOSIS AND ADVANCED CLINICOPATHOLOGICAL FEATURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC) ARE ASSOCIATED WITH CYTOPLASMIC SUBCELLULAR LOCALIZATION OF HIF-2α

Investigating the association of cytoplasmic and nuclear HIF-2 expression with cancer specific survival (CSS) in clear cell renal cell carcinoma

Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models

Cancers as wounds that do not heal : Differences and similarities between renal regeneration/repair and renal cell carcinoma

437 GAIN OF CHROMOSOME 8Q IS ASSOCIATED WITH METASTASES AND POOR SURVIVAL OF PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA

MP35-06 EFFECTS OF DENDRITIC CELL-BASED AD-GM∙CAIX VACCINE AS MONOTHERAPY OR IN COMBINATION WITH SUNITINIB IN AN IMMUNOCOMPETENT MOUSE MODEL OF METASTATIC RENAL CELL CARCINOMA

Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location

Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system

Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience

Safety and efficacy of dendritic cell immunotherapy with ad-GMCAIX in an immunocompetent preclinical tumor model of renal cell carcinoma

Abstract 1563: In vivo safety and efficacy of a novel dendritic cell based Ad-GMCAIX vaccine with activity against renal cell carcinoma

304 DC-AD-GMCAIX BASED VACCINE THERAPY IS SAFE AND EFFECTIVE IN IMMUNOCOMPETENT MURINE KIDNEY CANCER TUMOR MODELS

Dominant B-cell epitopes from cancer/stem cell antigen SOX2 recognized by serum samples from cancer patients

Expression of novel alternatively spliced isoforms of the oct-1 transcription factor

Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor

Factors to consider when interrogating 3D culture models with plate readers or automated microscopes

Functional Outcome After Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation With Intraoperative Cochlear Nerve Monitoring

Suchergebnisse filtern